Efficacy and Safety of the APGO Algorithm for Automated Insulin Delivery: The RENEW Study
Status: Recruiting
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The Medtrum TouchCare Nano system with the APGO algorithm is the only patch pump-based automated insulin delivery system available in the Czech Republic. However, until now, no prospective clinical study has evaluated its efficacy and safety under real-world conditions. The RENEW study is the first to address this topic.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• patients with T1D
• type 1 diabetes for ≥1 years
• ≥ 18 years old
• written informed consent prior to starting study related activity
Contact Information
Primary
Jan Soupal
jan.soupal@seznam.cz
+420775654343
Backup
Dat Do
datdoquoc@seznam.cz
+420608220784
Time Frame
Start Date: 2025-06-19
Estimated Completion Date: 2028-06-19
Participants
Target number of participants: 200
Treatments
Experimental: Patients with TouchCare Nano A8 insulin pump with the APGO system
Patients with type 1 diabetes, who initiated use of the TouchCare Nano A8 insulin pump with the APGO system.
Related Therapeutic Areas
Sponsors
Leads: Charles University, Czech Republic